In AMA‐negative PBC, alternate autoantigens, including gp210, and Sp100, may play a pathogenic role, and serve as diagnostic markers, particularly in seronegative patients with prominent portal inflammation [2, 9]. The gene discussed is NUP210; the disease is primary biliary cholangitis.